SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

Correspondence Activity Detail

Liminatus Pharma, Inc. (LIMN, LIMNW) (CIK 0001971387) (LIMN)
Activity window: Nov. 12, 2025 to Nov. 11, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
1.5 / 10
Correspondence-letter component
1.0
AI sentiment component
0.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Feb. 11, 2026. These dates describe different events.

Correspondence Filings
1
Keyword Matches
0
Latest Activity
Feb. 11, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Feb. 11, 2026 CORRESP Neutral/Informational Moderate Liminatus Pharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to have the stat… Read Filing EDGAR
Feb. 11, 2026 CORRESP Neutral/Informational Moderate Liminatus Pharma, Inc. has submitted a request for the acceleration of the effective date of their Registration Statement on Form S-1. This request, made by Maxim Group LLC as the… Read Filing EDGAR
Jan. 6, 2026 UPLOAD Neutral/Informational Moderate The SEC has informed Liminatus Pharma, Inc. that they do not intend to review the company's draft registration statement submitted on December 31, 2025. The SEC requests that the … Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.